Strober B, Krueger J, Magnolo N, Vender R, Toth D, Thaci D, Wang M, Cioffi C, Madden C, Warren R. Bimekizumab versus Ustekinumab Efficacy Across Subgroups of Patients with Moderate to Severe Plaque Psoriasis: Results from the Multicenter, Randomized, Double-Blinded Phase 3 BE VIVID Trial. J of Skin [Internet]. 2021 Jan. 1 [cited 2024 Jul. 4];5(1):s16. Available from: https://jofskin.org/33014/index.php/skin/article/view/1169